Cite
MLA Citation
Michael E Scheurer et al.. “Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.” Neuro-oncology advances, vol. 4, no. 1, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100168590798.0x000001